Coronavirus

RELIEF CONFIRMS RELEASE OF 60-DAY Findings
Apr13

RELIEF CONFIRMS RELEASE OF 60-DAY Findings

RELIEF CONFIRMS RELEASE OF 60-DAY FINDINGS FROM PHASE 2B/3 CLINICAL TRIAL OF INTRAVENOUS RLF-100™ (AVIPTADIL) 30 March 2021 60-day results have been presented by Relief’s partner, NeuroRx, Inc. Geneva, Switzerland, March 30, 2021 – RELIEF THERAPEUTICS Holding AG (SIX: RLF, OTCQB: RLFTF) (“Relief”), a biopharmaceutical company with its lead compound RLF-100™ (aviptadil) in advanced clinical development to treat critically-ill COVID-19...

Read More
Why has Covid’s toll been surprisingly low across much of Africa and Asia?
Mar10

Why has Covid’s toll been surprisingly low across much of Africa and Asia?

By David Leonhardt Good morning. Why has Covid’s toll been surprisingly low across much of Africa and Asia? ‘An epidemiological whodunit’ It’s one of the biggest mysteries about Covid-19: Why has the death toll been relatively low across much of Africa and Asia? The virus has killed a fraction of as many people on those continents — despite their relative lack of resources — as it has in Europe or the U.S.: This isn’t how public...

Read More
NeuroRx Announces that ZYESAMI™ (Aviptadil) has Successfully Demonstrated 10-Day Accelerated Recovery from Respiratory Failure in Critically Ill Patients with Covid-19
Mar03

NeuroRx Announces that ZYESAMI™ (Aviptadil) has Successfully Demonstrated 10-Day Accelerated Recovery from Respiratory Failure in Critically Ill Patients with Covid-19

NeuroRx Announces that ZYESAMI™ (Aviptadil) has Successfully Demonstrated 10-Day Accelerated Recovery from Respiratory Failure in Critically Ill Patients with Covid-19 Treated with High Flow Nasal Oxygen at 28-Day Interim Endpoint NeuroRx to File for Emergency Use Authorization in This Patient Population if Positive Results Continue to be Demonstrated at Day-60 Endpoint in Line with FDA’s New Guidance NEWS PROVIDED BY NeuroRx ...

Read More
NeuroRx and Relief Therapeutics Report Initial Phase 2b/3 Study Results Demonstrating Significant Benefit of ZYESAMI™
Feb09

NeuroRx and Relief Therapeutics Report Initial Phase 2b/3 Study Results Demonstrating Significant Benefit of ZYESAMI™

NeuroRx and Relief Therapeutics Report Initial Phase 2b/3 Study Results Demonstrating Significant Benefit of ZYESAMI™ in Reducing Hospital Stay Among Patients with Respiratory Failure due to Critical COVID-19 If Authorized for Use, ZYESAMI™ Would be First Treatment Specifically for Critically Ill Patients with Respiratory Failure RADNOR, Pa. and GENEVA, Feb. 9, 2021 /PRNewswire/ — NeuroRx, Inc. and Relief Therapeutics Holdings...

Read More
RELIEF AFFIRMS INITIATION OF PHASE 2/3
Feb09

RELIEF AFFIRMS INITIATION OF PHASE 2/3

RELIEF AFFIRMS INITIATION OF PHASE 2/3 TRIAL OF INHALED RLF-100™ (AVIPTADIL; ZYESAMI™) IN SEVERE COVID-19 PATIENTS 08 February 2021 Top-line data from intravenous RLF-100™ phase 2b/3 trial expected to be released this month Geneva, Switzerland, February 08, 2021 – RELIEF THERAPEUTICS Holding AG (SIX: RLF, OTCQB: RLFTF) (“Relief” or the “Company”) affirms that its collaboration partner NeuroRx, Inc. has...

Read More
A Swiss biotech firm developing a Covid treatment has seen its share price soar 38,000% this year
Jan17

A Swiss biotech firm developing a Covid treatment has seen its share price soar 38,000% this year

A Swiss biotech firm developing a Covid treatment has seen its share price soar 38,000% this year Medical staff examine a patient in the Covid-19 intensive care unit at United Memorial Medical Center in Houston on Nov. 16, 2020. Go Nakamura | Getty Images KEY POINTS Relief Therapeutics Chairman Ram Selvaraju told CNBC that Relief Therapeutics and NeuroRx had been in contact with the HSS’ Operation Warp Speed, and expects topline data...

Read More
Dr. Fauci Says When We’ll Get Back to Normal
Jan13

Dr. Fauci Says When We’ll Get Back to Normal

Dr. Fauci Says When We’ll Get Back to Normal With COVID-19 deaths surpassing 4,000 Americans on some days, you probably want protection. You want your vaccine. But reports across the nation indicate that some people are having a hard time getting theirs. At this rate, when will enough people be vaccinated so that we can have herd immunity and get back to some level of “normality?” Dr. Anthony Fauci, the...

Read More
A Swiss biotech firm developing a Covid treatment has seen its share price soar 38,000% this year
Jan07

A Swiss biotech firm developing a Covid treatment has seen its share price soar 38,000% this year

A Swiss biotech firm developing a Covid treatment has seen its share price soar 38,000% this year KEY POINTS Relief Therapeutics Chairman Ram Selvaraju told CNBC that Relief Therapeutics and NeuroRx had been in contact with the HSS’ Operation Warp Speed, and expects topline data from its late-stage trial of RLF-100 in January. Relief Therapeutics had a market cap of less than 100 million Swiss francs ($113 million) at the end of July,...

Read More
First U.S. Case Of New Covid Mutation Discovered In Colorado
Jan07

First U.S. Case Of New Covid Mutation Discovered In Colorado

First U.S. Case Of New Covid Mutation Discovered In Colorado A new, highly contagious coronavirus variant that was first identified in Britain has reached the United States, officials in Colorado confirmed Tuesday, reporting the first known U.S. case of the strain more than two weeks after it was discovered — a worrying development as Covid-19 infections and deaths climb nationwide. KEY FACTS The variant was discovered in a man in his...

Read More
New Years Around The World
Jan01

New Years Around The World

New year, new rules: World celebrates 2021 through COVID restrictions By JOSEPH WILKINSON NEW YORK DAILY NEWS | DEC 31, 2020 AT 6:57 PM Billions of people around the world celebrated the beginning of 2021 on Friday despite varying coronavirus restrictions. New Zealanders had it first and best, celebrating as normal because the country has no active COVID-19 cases. People in Manila, Philippines, watch a drone show during New...

Read More
Relief Therapeutics Hldg AG (OTC: RLFTF) Gaining as RLF-100 (aviptadil) Top Line Data Looms
Dec28

Relief Therapeutics Hldg AG (OTC: RLFTF) Gaining as RLF-100 (aviptadil) Top Line Data Looms

Relief Therapeutics Hldg AG (OTC: RLFTF) Gaining as RLF-100 (aviptadil) Top Line Data Looms BY JACOB WATSON ON DECEMBER 20, 2020 Microcapdaily continues to cover the exciting story of Relief Therapeutics Holding SA (SWX: RLF) (OTCQB: RLFTF) that skyrocketed up the charts earlier this year as its covid-19 treatment RLF-100 (aviptadil) continues to show significant potential to treat patients who are already in the Intensive Care Unit...

Read More

Challenges to Manufacturing in 2020

As we finish the year 2020, we have learned a lot when it comes to Manufacturing. Many manufacturers have made a pivot to adjust to COVID requests for PPE. Some have seen an opportunity and made a Pivot in a different direction. . How do you know when the time is right to pivot in manufacturing? Join us as we hear from experts around knowing when to pivot. The World Trade Center will discuss import and export matters both in and out...

Read More
Nine New Bills For COVID-19.
Dec10

Nine New Bills For COVID-19.

The Alliance held our December Membership Meeting today with a comprehensive update from SJPH, an outline on the 5 Star Certification timeline, Education opening updates, and grant information.  Here is the LINK to view the recording of the meeting in its entirety. Governor Jared Polis signed nine bills into law yesterday that will provide broad relief to those impacted by COVID-19. Monies will be distributed by local governments and...

Read More
Unusual Symptoms of COVID-19
Nov29

Unusual Symptoms of COVID-19

Unusual Symptoms of COVID-19 You Need to Know About GETTY IMAGES From nose to toes, doctors continue to discover uncommon signs of coronavirus infection by Rachel Nania, AARP, Updated November 23, 2020 ‘COVID toes’ Loss of taste or smell Diarrhea, nausea, vomiting and severe appetite loss Headaches, dizziness and confusion Hallucinations  Blood clots Hearing loss High blood sugar Fever, cough and shortness of breath are...

Read More
First COVID-19 Test for Self-Testing at Home
Nov18

First COVID-19 Test for Self-Testing at Home

Coronavirus (COVID-19) Update: FDA Authorizes First COVID-19 Test for Self-Testing at Home   Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the first COVID-19 diagnostic test for self-testing at home and that provides rapid results. The Lucira COVID-19 All-In-One Test Kit is a molecular (real-time loop mediated amplification reaction) single use test that is intended to detect the...

Read More
COVID-19 Level Moving to RED Friday Nov 20th!
Nov18

COVID-19 Level Moving to RED Friday Nov 20th!

La Plata County Will Move to COVID-19 Dial Level Red: Severe Risk; Immediate Community Action Needed to Preserve Critical Services and Health Care Capacity Durango, Colo.: To reduce community transmission and slow a dramatic rise in cases that threatens our ability to maintain hospital capacity and the workforce in critical services, San Juan Basin Public Health (SJBPH) and the Colorado Department of Public Health and Environment...

Read More
How to celebrate Thanksgiving safely this year, according to health experts
Nov17

How to celebrate Thanksgiving safely this year, according to health experts

How to celebrate Thanksgiving safely this year, according to health experts Turkey day isn’t canceled, but with all the efforts to slow the spread of COVID-19, expect it to be different. Oct. 1, 2020, 1:54 PM MDT / Updated Nov. 6, 2020, 2:42 PM MST / Source: TODAY By Ronnie Koenig Thanksgiving is usually a time for friends and family to gather and celebrate together. But this year, the Centers for Disease Control and Prevention...

Read More
Will Thanksgiving cause an increase in COVID-19 cases? It did in Canada.
Nov17

Will Thanksgiving cause an increase in COVID-19 cases? It did in Canada.

Will Thanksgiving cause an increase in COVID-19 cases? It did in Canada. BY CAITLIN O’KANE NOVEMBER 17, 2020 / 6:15 PM / CBS NEWS Canadians celebrated their Thanksgiving last month, and if the day can teach anything to Americans, it’s that gathering for the holidays can lead to an increase in COVID-19 cases. Canada saw an increase of positive coronavirus tests two weeks after its holiday — the typical incubation period for...

Read More
Enrollment of 150 patients in phase 2b/3 trial of RLF-100™
Nov14

Enrollment of 150 patients in phase 2b/3 trial of RLF-100™

NeuroRx and Relief Therapeutics announce enrollment of 150 patients in phase 2b/3 trial of RLF-100™ for Critical COVID-19 with Respiratory Failure – Observations of rapid recovery noted on chest x-ray and no drug-related Serious Adverse Events reported NEWS PROVIDED BY NeuroRx  Nov 13, 2020, 05:00 ET RADNOR, Pa. and GENEVA, Nov. 13, 2020 /PRNewswire/ — NeuroRx, Inc. and Relief Therapeutics Holdings AG (SIX:RLF,OTCBB:RLFTF)...

Read More
La Plata County Moves to ‘Level Orange: High Risk’
Nov14

La Plata County Moves to ‘Level Orange: High Risk’

La Plata County Moves to ‘Level Orange: High Risk’   by Claire Ninde | Nov 11, 2020 | Education/Health To reduce community transmission and slow a dramatic rise in cases that threatens our school learning models and our local economy, San Juan Basin Public Health (SJBPH) and the Colorado Department of Public Health and Environment (CDPHE) are moving La Plata County to COVID-19 Level Orange: High Risk (formerly known as ‘Safer at...

Read More